Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jul 15;132(14):e161572.
doi: 10.1172/JCI161572.

Microbially derived polyunsaturated fatty acid as a modulator of gastrointestinal motility

Comment

Microbially derived polyunsaturated fatty acid as a modulator of gastrointestinal motility

Yang Xiao et al. J Clin Invest. .

Abstract

Gastrointestinal (GI) motility requires coordination among several cell types in the intestinal epithelium and the neuromuscular apparatus. A disruption in GI motility was primarily attributed to disruption of this coordinated effort among different host cells, but recent studies have begun to uncover how the products of gut microbiota can alter GI motility by modulating the function of different host cells and the interactions among them. In this issue of the JCI, Chen, Qiu, et al. used a reverse translation approach, isolating a Shigella sp. - peristaltic contraction-inhibiting bacterium (PIB) - from a cohort of patients with intractable constipation. They identified an ω-3 polyunsaturated fatty acid (PUFA), docosapentaenoic acid (DPA), produced by this Shigella variant, as an important driver of constipation using a series of microbiologic, biochemical, and genetic manipulations combined with in vitro and in vivo studies. This finding advances the field, given that production of DPA is rare in the human gut and appears to have a distinct effect on GI physiology.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: PCK is an ad hoc consultant for Pendulum Therapeutics, IP Group Inc., Novome Biotechnologies, and Intrinsic Medicine. PCK holds the patent US20170042860A1 “Methods and materials for using Ruminococcus gnavus or Clostridium sporogenes to treat gastrointestinal disorders” for use of tryptamine producing bacteria to treat gastrointestinal disorders. Mayo Clinic and PCK have a financial interest related to use of tryptamine-producing bacteria.

Figures

Figure 1
Figure 1. Schematic summary of mechanisms underlying microbial modulation of GI physiology.
The conventional, discovery-to-translation approach of studying microbial modulation of GI transit has focused on the effect of known bacterial metabolites, such as short-chain fatty acids and tryptophan metabolites (–12); cell wall components like LPS; and bacterial functions such as transformation of primary bile acids, on the different cell types (–9, 15, 16). In contrast, the Chen, Qiu, et al. study used a reverse translation approach, starting with patients diagnosed with IFC and identifying the microbial meditator DPA that prolonged GI transit. Similar to other metabolites, DPA likely alters GI transit by an effect on the enteric nervous system (17). SMCs, smooth muscle cells; 5-HT, serotonin; 5-HTR, serotonin receptor; CFTR, cystic fibrosis transmembrane conductance regulator;

Comment on

References

    1. Forootan M, et al. Chronic constipation: a review of literature. Medicine (Baltimore) 2018;97(20):e10631. doi: 10.1097/MD.0000000000010631. - DOI - PMC - PubMed
    1. Mearin F, et al. Bowel disorders. Gastroenterology. doi: 10.1053/j.gastro.2016.02.031. [published online February 16, 2016]. - DOI - PubMed
    1. Simren M, et al. Update on Rome IV criteria for colorectal disorders: implications for clinical practice. Curr Gastroenterol Rep. 2017;19(4):15. doi: 10.1007/s11894-017-0554-0. - DOI - PMC - PubMed
    1. Touw K, et al. Mutual reinforcement of pathophysiological host-microbe interactions in intestinal stasis models. Physiol Rep. 2017;5(6):e13182. - PMC - PubMed
    1. Kashyap PC. Eat your curry. Cell Host Microbe. 2015;18(4):385–387. doi: 10.1016/j.chom.2015.10.005. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances